drugset / Trial / NCT00150371

Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration

NCT00150371 ↗

Phase 3 Completed 1100 enrolled Viatris Inc.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to assess the effectiveness of an atorvastatin treatment regimen involving starting doses between 10 and 80 mg, followed by a single-step titration (except for subjects started at 80mg), if required

Timeline

Start
2004-06
Primary completion
—
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg —
Subject Atorvastatin Small molecule 20 mg —
Subject Atorvastatin Small molecule 40 mg —
Subject Atorvastatin Small molecule 80 mg —

Indications